ARTICLE | Company News
Kyorin, R-Pharm deal
November 3, 2014 8:00 AM UTC
Kyorin granted R-Pharm exclusive rights to develop and market overactive bladder drug imidafenacin in Russia, Belarus and Kazakhstan. Kyorin and Ono Pharmaceutical Co. Ltd. (Tokyo:4528, Osaka, Japan)...